drugset / Trial / NCT03733626

Clinical Outcomes Associated With the Use of ViviGen® for the Treatment of Lumbar Degenerative Disc Disease

NCT03733626 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

The objective of this study is to perform a prospective, randomized, controlled clinical trial to compare radiographic fusion rates and patient reported outcomes, including pain and function preoperatively and postoperatively, using Depuy ViviGen® Cellular Bone Matrix mixed with cortical/cancellous allograft in conjunction with an approved Depuy Synthes pedicle screw system compared to autograft mixed with cortical/cancellous allograft in conjunction with the same DePuy Synthes pedicle screw system used for a one or two - level posterolateral lumbar fusion.

Timeline

Start
2019-03-19
Primary completion
2024-06-25
Completion
2024-06-25

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject ViviGen® Cellular Bone Matrix Unknown — —